Management of ulcerative colitis in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease.

Shu Chen Wei; Ting An Chang; Te Hsin Chao; Jinn Shiun Chen; Jen Wei Chou; Yenn Hwei Chou; Chiao Hsiung Chuang; Wen Hung Hsu; Tien Yu Huang; Tzu Chi Hsu; Chun Chi Lin; Hung Hsin Lin; Jen Kou Lin; Wei Chen Lin; Yen Hsuan NI; Ming Jium Shieh; I Lun Shih; Chia Tung Shun; Yuk Ming Tsang; Cheng Yi Wang; Horng Yuan Wang; Meng Tzu Weng; Deng Chyang WU; Wen Chieh WU; Hsu Heng Yen; Jau Min Wong

Return

Management of ulcerative colitis in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease.

Author: Shu Chen WEI ¹ ; Ting An CHANG ; Te Hsin CHAO ; Jinn Shiun CHEN ; Jen Wei CHOU ; Yenn Hwei CHOU ; Chiao Hsiung CHUANG ; Wen Hung HSU ; Tien Yu HUANG ; Tzu Chi HSU ; Chun Chi LIN ; Hung Hsin LIN ; Jen Kou LIN ; Wei Chen LIN ; Yen Hsuan NI ; Ming Jium SHIEH ; I Lun SHIH ; Chia Tung SHUN ; Yuk Ming TSANG ; Cheng Yi WANG ; Horng Yuan WANG ; Meng Tzu WENG ; Deng Chyang WU ; Wen Chieh WU ; Hsu Heng YEN ; Jau Min WONG
Author Information

1. Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan. jmwong@ntu.edu.tw
Publication Type:Review
Keywords: Taiwan; Ulcerative colitis; Inflammatory bowel disease; Disease management; Consensus statements
MeSH: Biological Factors; Colitis; Colitis, Ulcerative*; Colon; Consensus*; Diagnosis; Diagnosis, Differential; Disease Management; Expert Testimony; Hepatitis B virus; Humans; Incidence; Inflammation; Inflammatory Bowel Diseases*; Prevalence; Quality of Life; Steroids; Taiwan*; Tuberculosis; Ulcer*
From:Intestinal Research 2017;15(3):266-284
CountryRepublic of Korea
Language:English
Abstract: Ulcerative colitis (UC) is an inflammatory bowel disease characterized by chronic mucosal inflammation of the colon, and the prevalence and incidence of UC have been steadily increasing in Taiwan. A steering committee was established by the Taiwan Society of Inflammatory Bowel Disease to formulate statements on the diagnosis and management of UC taking into account currently available evidence and the expert opinion of the committee. Accurate diagnosis of UC requires thorough clinical, endoscopic, and histological assessment and careful exclusion of differential diagnoses, particularly infectious colitis. The goals of UC therapy are to induce and maintain remission, reduce the risk of complications, and improve quality of life. As outlined in the recommended treatment algorithm, choice of treatment is dictated by severity, extent, and course of disease. Patients should be evaluated for hepatitis B virus and tuberculosis infection prior to immunosuppressive treatment, especially with steroids and biologic agents, and should be regularly monitored for reactivation of latent infection. These consensus statements are also based on current local evidence with consideration of factors, and could be serve as concise and practical guidelines for supporting clinicians in the management of UC in Taiwan.